These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17236120)

  • 1. Mouse models of liver fibrosis.
    Weiler-Normann C; Herkel J; Lohse AW
    Z Gastroenterol; 2007 Jan; 45(1):43-50. PubMed ID: 17236120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling liver fibrosis in rodents.
    Constandinou C; Henderson N; Iredale JP
    Methods Mol Med; 2005; 117():237-50. PubMed ID: 16118456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
    Yu J; Wu CW; Chu ES; Hui AY; Cheng AS; Go MY; Ching AK; Chui YL; Chan HL; Sung JJ
    Biochem Biophys Res Commun; 2008 Aug; 372(4):571-7. PubMed ID: 18503750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal models.
    Luedde T; Beraza N; Trautwein C
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S43-6. PubMed ID: 16958671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
    Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
    Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets contribute to the reduction of liver fibrosis in mice.
    Watanabe M; Murata S; Hashimoto I; Nakano Y; Ikeda O; Aoyagi Y; Matsuo R; Fukunaga K; Yasue H; Ohkohchi N
    J Gastroenterol Hepatol; 2009 Jan; 24(1):78-89. PubMed ID: 18624898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.
    Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y
    Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis.
    Park JH; Jo JH; Kim KH; Kim SJ; Lee WR; Park KK; Park JB
    J Gene Med; 2009 Sep; 11(9):824-33. PubMed ID: 19554625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
    Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M
    Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
    Popov Y; Schuppan D
    Hepatology; 2009 Oct; 50(4):1294-306. PubMed ID: 19711424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental models of hepatic fibrosis: a review.
    Tsukamoto H; Matsuoka M; French SW
    Semin Liver Dis; 1990 Feb; 10(1):56-65. PubMed ID: 2110685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats.
    Lam HB; Yeh CH; Cheng KC; Hsu CT; Cheng JT
    Neurosci Lett; 2008 Jun; 438(1):90-5. PubMed ID: 18472332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model.
    Jang JH; Kang KJ; Kim YH; Kang YN; Lee IS
    Transplant Proc; 2008 Oct; 40(8):2700-3. PubMed ID: 18929839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
    Iwaisako K; Hatano E; Taura K; Nakajima A; Tada M; Seo S; Tamaki N; Sato F; Ikai I; Uemoto S; Kinoshita M
    J Hepatol; 2008 Nov; 49(5):768-78. PubMed ID: 18804890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis.
    Loebermann M; Sombetzki M; Langner C; Fuchsbichler A; Gumhold J; Silbert D; Riebold D; Holtfreter M; Fickert P; Nizze H; Trauner M; Reisinger EC
    Trop Med Int Health; 2009 Nov; 14(11):1418-25. PubMed ID: 19747186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis.
    Peng XD; Dai LL; Huang CQ; He CM; Yang B; Chen LJ
    Biochem Biophys Res Commun; 2009 Oct; 388(1):31-4. PubMed ID: 19632202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.